Goldman Sachs Starts STERIS (STE) at Neutral
- S&P, Nasdaq hit highs on gains in health, tech stocks
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Sibanye Gold (SBGL) to Acquire Stillwater Mining Company (SWC) in $2.2B Deal
- Exclusive: ECB rejects Monte Paschi's request for more time to raise cash - source
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Goldman Sachs initiated coverage on STERIS (NYSE: STE) with a Neutral rating and a price target of $71.
Shares of STERIS closed at $66.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Assumes/Upgrades US Foods (USFD) to Buy
- Broadcom (AVGO) PT Raised to $215 at Oppenheimer
- Goldman Sachs Starts Mednax (MD) at Neutral
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!